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G protein-coupled receptorAlthough the regulation of membrane receptor activation is known to be crucial for molecular sig-
nal transduction, the molecular mechanism underlying receptor activation is not fully elucidated.
Here we study the physicochemical nature of membrane receptor behavior by investigating the
characteristic molecular vibrations of receptor ligands using computational chemistry and infor-
matics methods. By using information gain, t-tests, and support vector machines, we have identiﬁed
highly informative features of adenosine receptor (AdoR) ligand and corresponding functional
amino acid residues such as Asn (6.55) of AdoR that has informative signiﬁcance and is indispens-
able for ligand recognition of AdoRs. These ﬁndings may provide new perspectives and insights into
the fundamental mechanism of class A G protein-coupled receptor activation.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction colleagues have reported that agonist-biased activation of class AMolecular recognition of membrane receptors in biological sys-
tems plays a crucial role in intercellular and intracellular transduc-
tion of signals. G protein-coupled receptors (GPCRs), also known as
seven-transmembrane-segment receptors (7TMRs), are integral
membrane proteins that are connected by 3 extracellular and 3
intracellular loops of variable length, and they transmit ligand
information by interacting with trimeric GTP-binding proteins or
b-arrestins to modulate intracellular pathways. GPCRs constitute
the largest family of proteins encoded in the human genome
[1,2] and play pivotal roles in the transmission of extracellular sig-
nals into cells. This family of proteins is known to react with a
broad range of ligands such as hormone molecules [3], volatile
organic compounds [4], tastants [5,6], and even photons [7]. They
are also major targets of modern drugs and are associated with
more than one-third of pharmaceuticals [8].
Among the GPCR classes, rhodopsin-like class A GPCRs have the
simplest polypeptide ends and the greatest number of reported
three-dimensional (3-D) structures [9]. Firing of a signal and the
accompanying information transfer is elicited by an agonist that
activates its cognate receptor; however, the molecular mechanism
underlying receptor activation is not simple. Lefkowitz and hisGPCRs is related to b-arrestins [10–14].
The fundamental mechanism of olfaction mediated by odorant
receptors, members of the class A GPCR family, is controversial
[15–17]. Various attempts have been made to describe the molec-
ular mechanism of ligand-receptor recognition during olfaction,
such as the classical binding theory and vibration theory [18–20]
of electron transfer [21–23]. The former theory, in which ligand
speciﬁcity is explained by its molecular shape, has been developed
into the pharmacophore concept and is generally accepted by
researchers. However, this theory is not sufﬁcient to account for
the diversity of ligands and complexity of GPCR agonism. In recent
decades, various models and experiments have been used to
explain the activation of the olfactory receptor, a class A GPCR,
by means of a molecular vibrationally assisted electron tunneling
mechanism [17,21–24].
Borea et al. reported the thermodynamic discrimination in
AdoRs [25,26] and neuronal nicotinic receptor [27] as a method
of studying ligand-receptor interactions. According to these papers,
agonistic binding was both enthalpy- and entropy-driven, while
antagonistic binding was entirely entropy-driven. Pivonka made
a report that the spectral trends of infrared (IR) and/or Raman anal-
yses of human estrogen receptor b (ER-b) ligands mirror the trends
in binding strength values obtained from biological assays [28].
Takane et al. showed the existence of a structure-odor relationship
by a ligand-based approach using EigenVAlue (EVA) descriptor and
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EVA is a unique approach based on IR range molecular vibrational
frequencies [30]. More recently, computational approaches were
used to search for molecular vibration-activity relationships in
the agonism of histamine and adenosine receptors, and the authors
suggested that the molecular vibrational frequency pattern may
serve as a possible molecular descriptor for the classiﬁcation of
agonist and antagonist class A GPCR ligands [31,32]. Thus, in this
study, we focus on the possible characteristics that contribute to
the activation of class A GPCRs rather than their conventional bio-
chemical properties.
Although class A GPCRs have relatively low sequence similarity,
their endogenous agonists are highly conserved. Four AdoR sub-
types have been identiﬁed: AdoRA1, AdoRA2A, AdoRA2B, and
AdoRA3 [33]. While each AdoR subtype interacts with and is acti-
vated/inactivated by speciﬁc ligands, biogenic nucleoside adeno-
sine commonly activates all AdoRs. Adenosine interacts with
AdoRs involved in various diseases including cardiac ischemia,
arrhythmia, neurodegeneration, diabetes, glaucoma, and inﬂam-
mation [34]. It also plays an important role in managing asthma
and arthritis, and in ﬁnding applications for the treatment of pain,
cancer and other disorders [35]. We thus designed and utilized a
computational approach to investigate characteristic molecular
vibrations of AdoR agonists and non-agonists (antagonists and
inverse agonists).
2. Materials and methods
To facilitate their classiﬁcation, AdoR ligands were grouped into
two categories: agonists and non-agonists. Non-agonists included
antagonists and inverse agonists that block and decrease agonist-
mediated receptor activation, respectively.
2.1. Dataset
A 64-ligand dataset consisting of 30 AdoR agonists and 34 non-
agonists was used (Table S1). Three-dimensional structure data
format (SDF) ﬁles for the AdoR ligands were downloaded from
the PubChem Compound Database at the National Center for Bio-
technology Information and subjected to geometry optimization,
molecular vibrational pattern analysis, and further study.2.2. Molecular vibration calculation and data formulation
First, geometry optimization was carried out since the calcula-
tion of molecular vibrational frequencies requires a given 3-D
structure of a given molecule. The theoretical 3-D conformer SDF
of each molecule was modeled as a single low-energy conforma-
tion by using the Becke and Lee, Yang, Parr correlation (BLYP) den-
sity functional theory (DFT) and standard split-valence basis set 6-
31G(d,p). The results of geometry optimization were then sub-
jected to vibrational frequency calculations. All calculations of
geometry optimization and normal modes of molecular vibration
were performed using the GAMESS program package [36,37].
To compare the molecular vibration patterns of AdoR ligands
while maintaining their characteristics of molecular vibration,
the corralled intensity of molecular vibrational frequency (CIMVF)
of each ligand was generated as a vector of 800 elements as previ-
ously reported [32]. To restrict the number of non-discrete vibra-
tional frequency spaces and retain the properties of molecular
vibration, we discretized the molecular vibration dataset of each
AdoR ligand as follows.
Let ðxi; aiÞ represent the ith pair of vibrational frequency and
amplitude (intensity) among n observed pairs. Transform xi by
yi ¼ j xic j where jxj is the largest integer not greater than x and c isthe corral size. Denote M distinct (ascending) integer values of as
fz1; :::; zMg and represent Im for the set of indices corresponding to
the discretized zm (where Im ¼ fijyi ¼ zm; i  f1; ::;nggÞ for
m ¼ 1; . . . ;M. If bm is the sum of amplitudes with indices (a0is) corre-
sponding to Im form ¼ 1;    ;M, then ðz1; b1Þ; ðz2; b2Þ;    ; ðzM; bMÞ
become our new discretized data pairs in the range of
0 6 zm 6 4000=c.
Finally, the CIMVF of a ligand is represented as a one-dimen-
sional vector containing 800 elements of vibrational intensity for
the vibrational frequency range from 0 to 4000 cm1 by setting
the corral size c to 5 cm1. It should be noted that the CIMVF did
not correspond to the IR or Raman spectrum of the relevant ligand.
During feature selection, the corrals of molecular vibration were
regarded as features of each ligand.
2.3. Feature selection by information gain
The dimension of a dataset is the number of variables or
features that are measured with each observation. One of the chal-
lenges with high-dimensional datasets is that not all of the features
are important or informative for understanding the underlying
mechanism of a particular phenomenon. Feature selection is a
method for reducing meaningless and less informative features.
The overall procedure of feature selection involves scoring each
potential feature according to a particular feature selection metric.
Scoring involves separately counting the occurrences of a feature in
positive- and negative-class training examples, and then comput-
ing a function of these [38]. The information gain (IG) yielded from
a dataset is given by the relative entropy (also known as Kullback–
Leibler divergence [39]) between the prior and posterior probabil-
ities [40]. IG measures the amount of information about the class
prediction in bits, if the only information available is the presence
of a feature and the corresponding class distribution [41].
The IG is
IGðSx; xiÞ ¼ HðSxÞ 
X
v¼ValuesðxiÞ
jSxi¼v j
jSxj  HðSxi¼vÞ
where H is the entropy function, Sx is the set of training examples, xi
is the vector of the ith variable in the set, and jSxi¼v j / jSxj is the frac-
tion of examples of the ith variable having value m.
Thus, we applied IG-based feature selection to identify the cor-
rals of molecular vibrational frequency that were the most infor-
mative among the 800 elements for binary classiﬁcation of AdoR
ligands as agonists or non-agonists. An IG of zero implied that
the corresponding feature was no better than that of random sam-
pling. We trained and tested the procedure by applying leave-one-
out cross-validation to each ligand. The calculation of IG was per-
formed using the Weka machine learning package [42].
2.4. Parametric and non-parametric analyses of informative features
Because each group of agonists and non-agonists has a ten-
dency to show intensities in speciﬁc frequency ranges, we wanted
to identify a set of meaningful frequency ranges where the mean
responses of the two groups were signiﬁcantly different. After ana-
lyzing the intensities over the range of 800 features, a subset of 18
features were selected for testing the equality of the mean intensi-
ties of the two groups, where a was equal to 0.01 in two-sample t-
tests.
We also selected meaningful features by using the linear sup-
port vector machine (SVM) to compare the t-test results. For each
feature, the agonist and non-agonist groups were classiﬁed by 10-
fold cross validation using the SVM classiﬁer. Here, data sets with
particular features were randomly divided in two sets; 90% of sam-
ples were assigned into a training set and 10% of the samples were
Table 1
The IG scores, t-test, and SVM analyses of informative features.
Feature
No.
Wavenumber IG score t-Test
(P < 0.01)
SVM
(n = 18)
238 1190–1195 0.2667597015 d d
211 1055–1060 0.2279074627 d d
198 990–995 0.2275462687 d
125 625–630 0.201458209 d
203 1015–1020 0.1974880597 d d
319 1595–1600 0.1816791045 d d
200 1000–1005 0.1806432836 d d
123 615–620 0.1765880597 d
208 1040–1045 0.1765880597 d
240 1200–1205 0.1603910448 d
228 1140–1145 0.1600820896
136 680–685 0.1579985075
214 1070–1075 0.1566671642 d d
Mean IG 0.1543408692
230 1150–1155 0.152541791
210 1050–1055 0.1404716418 d
239 1195–1200 0.1404716418
268 1340–1345 0.1404716418
305 1525–1530 0.1395567164
96 480–485 0.1216746269
91 455–460 0.1213835821
322 1610–1615 0.1211
574 2870–2875 0.1211
700 3500–3505 0.1211
334 1670–1675 0.1059044776 d
340 1700–1705 0.1059044776 d
584 2920–2925 0.1024522388
586 2930–2935 0.1024522388
727 3635–3640 0.1024522388
Fig. 2. Highly informative features for the classiﬁcation of AdoR ligands as agonists
(blue and green) and non-agonists (red and orange). (A) Wave numbers of features
for which the conﬁdence level (P-value) was below 0.01 in the t-test and selected
from support vector machines. The blue and green marks represent the informative
features of agonists and the red and orange marks represent those of non-agonists.
(B) Frequency distribution of the molecular vibration (wave number).
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ing set, and the performance of the trained classiﬁer was then eval-
uated based on the validation set. The mean classiﬁcation rate for
each part was used to determine the classiﬁcation rate of the cor-
responding frequency. After repeating this process for each feature,
we selected those showing the best performances with regard to
classiﬁcation rate, where the size of the best feature set was set
equal to that of the features selected using the t-test (n = 18). The
analyses were performed using MATLAB.
3. Results and discussion
3.1. Comparison of agonist and non-agonist molecular vibrational
patterns
To examine the global patterns in molecular vibrational fre-
quency, the mean vibrational intensities of AdoR agonists and
non-agonists according to their molecular vibrational frequency
were plotted (Fig. 1). The mean intensity value of the agonist group
differed signiﬁcantly from that of the non-agonist group across the
entire vibrational frequency range (P-value = 3.42  108, two-
sample t-test). According to the overall intensity plot, the two
groups showed differences within a certain frequency range. We
selected interesting sets of frequencies to further analyze the dif-
ferent behaviors of the two groups by using IG score, t-test, and
SVM.
3.2. IG ranking of informative features
Among the 800 corrals, 382 had vibrational intensities of 0. The
remaining 418 corrals were regarded as features containing molec-
ular vibrational information to be further analyzed. Each feature
within the feature space was ranked depending on its importance
for AdoR agonist and non-agonist classiﬁcation. After the IG score
was calculated for each AdoR ligand, only 28 features out of 418
showed IG scores larger than 0 (Table 1). The majority of features
with IG scores greater than the mean value were located between
wavenumbers 800 and 1800. This frequency range contained the
most discriminative features for testing the equality of mean inten-
sities between the agonist and non-agonist groups. Thus, it was
possible to focus our analysis on this frequency subset.
3.3. Comparison of selected features by using statistical analysis
To evaluate the selected features by using IG ranking, we used
statistical analyses (two-sample t-test and SVM) to compare the
classiﬁcation potential of these features to other feature lists pre-
pared from the same datasets by using statistical analyses. For
additional validation of the t-test analysis, the linear SVM classiﬁer,
a non-parametric technique, was applied to the same datasets.
As shown in Table 1 and Fig. 2, six features were commonly
selected from the three analyses within the wave number rangeFig. 1. The mean intensities of the two corralled intensities of molecular vibrational
frequency (CIMVFs) of adenosine receptor (AdoR) agonists (blue) and non-agonists
(red) according to the wave number of the molecular vibration.of 800–1800; IG ranking, t-test (P < 0.01), and SVM (n = 18). The
apparent differences in mean intensity and corresponding jumps
in ﬁring rates were predominantly found around wave numbers
1000 and 1600.
3.4. Considerations from molecular aspects
The numbers of features from each ligand counts from 57 (the-
ophylline) to 330 (UK-432097), and most of the features holding
relatively high intensities grouped near wave number 1600. For
example, the features around 1600 were apparent when the mean
intensity threshold was set to 9 (Fig. 3). The wave numbers around
Fig. 3. Distribution of the mean CIMVF intensity with a threshold of 9. When the
lower limit of the mean intensity was ﬁxed at 9, the occurrence number of features
grouped near wave number 1600. These wave numbers were derived from the
scissoring modes of vibration in the primary or secondary amines found in all of
AdoR agonists in this study.
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vibration in the primary or secondary amines commonly found in
all AdoR agonists. The molecular interaction of this moiety with
Asn253 (6.55; this number was adopted from the Ballesteros–
Weinstein nomenclature [43]) of AdoRA2A was found to be critical
in previous studies in which the crystal structures of human
AdoRA2A bound to its ligands were determined [44–47]. In addi-
tion, mutational analyses showed that mutations in this residue
disrupt the binding of both agonist and antagonist ligands. For
example, the Ki values for the Asn253 (6.55) AdoRA2A mutants
(N253A, N253S and N253Q [48]; N253D [49]), Asn250 (6.55)
AdoRA3 mutant (N250A [50]), and Asn254 (6.55) AdoRA1 mutant
(N254A [51]) could not be determined, as they lost their ability
to bind to either the agonist or antagonist with high afﬁnity. These
results indicated that the interaction between the amine moiety of
the ligand and the Asn (6.55) residue of AdoR is indispensable for
ligand binding and controls of AdoR activity. The molecular parts
of most of the selected features around wave number 1000 were
reported to participate in the interaction with the ribose moiety
of AdoR agonists [45,46].
The functions of proteins are governed by their dynamic charac-
teristics; membrane receptors also elicit their functions via struc-
tural dynamics. Many biological processes are controlled by
alterations in rates and relative populations rather than by a sim-
ple binary ‘‘on-off’’ switch [52]. Recently, Markov state models of
simpliﬁed GPCR dynamics were stitched into a single statistical
model to describe b2-adrenergic receptor (b2AR) activation [53].
As with the existence of receptor-speciﬁc agonists, antagonists,
and inverse agonists, the existence of biased agonists implies that
the binding afﬁnity and activation capability of a ligand should not
be regarded as the same action. Although molecular mechanisms
of ligand binding to GPCRs were reported from a variety of view-
points, the fundamental mechanism of GPCR activation is not yet
clear. The results of the current study showed that by using IG, t-
test, and SVM methods as cross-check validation, it was possible
to select highly informative features of molecular vibration for
ligand classiﬁcation of AdoR agonism.
To our knowledge, this is the ﬁrst reported informatics and sta-
tistical approach to elucidating the relationship between molecular
vibrations of ligands and their corresponding AdoRs. Though the
calculated vibrational spectrum in this study does not simulate
actual IR or Raman spectra, its patterns were consistent for the
molecular properties of each ligand; thus, we could not disregard
these ﬁndings. Selecting subsets of highly informative features
would be beneﬁcial and useful for developing and presenting
new approaches for ligand design and contribute to ligand and
drug discovery. When much more ligand data is gathered,characterization of AdoR ligand subtypes corresponding to their
cognate receptors by their molecular vibrational patterns will
become solid (data not shown), then targeted modiﬁcation of bind-
ing sites in ligands could be possible. Our ﬁndings are also
expected to give inspirational contribution to the elucidation of
the receptor activation mechanism via material transfer, such as
electron or proton, and/or biased agonism. Future work is required
to extend molecular vibration to the dynamics of membrane recep-
tor activation.
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